Cargando…

What’s new in HIV dermatology?

HIV has long been associated with a number of inflammatory, infectious, and neoplastic skin conditions. In the era of anti-retroviral therapy, we have discovered even more about the relationship between skin disease and chronic immunosuppression. In particular, clinicians still face the propensity o...

Descripción completa

Detalles Bibliográficos
Autores principales: Coates, Sarah J, Leslie, Kieron S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: F1000 Research Limited 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6600856/
https://www.ncbi.nlm.nih.gov/pubmed/31297183
http://dx.doi.org/10.12688/f1000research.16182.1
_version_ 1783431196890365952
author Coates, Sarah J
Leslie, Kieron S
author_facet Coates, Sarah J
Leslie, Kieron S
author_sort Coates, Sarah J
collection PubMed
description HIV has long been associated with a number of inflammatory, infectious, and neoplastic skin conditions. In the era of anti-retroviral therapy, we have discovered even more about the relationship between skin disease and chronic immunosuppression. In particular, clinicians still face the propensity of persons living with HIV to develop difficult-to-control viral infections, chronic skin inflammation, and pruritus and—particularly as patients age—various types of skin cancers. Here, we summarize recent updates in the field of HIV dermatology and make recommendations to providers caring for these patients.
format Online
Article
Text
id pubmed-6600856
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher F1000 Research Limited
record_format MEDLINE/PubMed
spelling pubmed-66008562019-07-10 What’s new in HIV dermatology? Coates, Sarah J Leslie, Kieron S F1000Res Review HIV has long been associated with a number of inflammatory, infectious, and neoplastic skin conditions. In the era of anti-retroviral therapy, we have discovered even more about the relationship between skin disease and chronic immunosuppression. In particular, clinicians still face the propensity of persons living with HIV to develop difficult-to-control viral infections, chronic skin inflammation, and pruritus and—particularly as patients age—various types of skin cancers. Here, we summarize recent updates in the field of HIV dermatology and make recommendations to providers caring for these patients. F1000 Research Limited 2019-06-28 /pmc/articles/PMC6600856/ /pubmed/31297183 http://dx.doi.org/10.12688/f1000research.16182.1 Text en Copyright: © 2019 Coates SJ and Leslie KS http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review
Coates, Sarah J
Leslie, Kieron S
What’s new in HIV dermatology?
title What’s new in HIV dermatology?
title_full What’s new in HIV dermatology?
title_fullStr What’s new in HIV dermatology?
title_full_unstemmed What’s new in HIV dermatology?
title_short What’s new in HIV dermatology?
title_sort what’s new in hiv dermatology?
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6600856/
https://www.ncbi.nlm.nih.gov/pubmed/31297183
http://dx.doi.org/10.12688/f1000research.16182.1
work_keys_str_mv AT coatessarahj whatsnewinhivdermatology
AT lesliekierons whatsnewinhivdermatology